Skip to content

Author

D. Qureshi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Abstract 15396: Comparative Efficacy and Safety of Apixaban versus Rivaroxaban in Obese Adults with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis

In obese or morbidly obese adults with NVAF, apixaban was associated with lower systemic embolization, myocardial infarction, gastrointestinal hemorrhage, and major bleeding than rivaroxaban, with no significant differences in ischemic stroke, intracranial bleeding, hemorrhagic stroke, or mortality.

M. Iqbal, M. Khan, Fazeel Ahmed et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.